We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer to Snap Up Cancer Drug Developer Trillium for $2.26 Billion
Pfizer to Snap Up Cancer Drug Developer Trillium for $2.26 Billion
Pfizer has entered into a $2.26 billion purchase agreement with Canadian drugmaker Trillium Therapeutics in a move to expand its portfolio of cancer treatments.